Sagimet Biosciences Inc.
Sagimet Biosciences Inc. is a drugs targeting the fatty acid synthase enzyme.
3
Funding Rounds
$185.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Me**** Pa**** | - | - | - |
| Be** Se******** | - | - | - |
| Ge**** Ke**** | - | - | |
| Ji*** J. Wu | - | - | |
| Go**** Ri***** | - | - | - |
| Ja*** F. Yo*** | - | - | |
| El******* Gr***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Sagimet Biosciences Inc. has raised a total of $105m in funding over 3 rounds.
Key Insights:
- Sagimet Biosciences Inc. , February 2021: $80m
- Sagimet Biosciences Inc. Series E round, August 2019: $25m
- Sagimet Biosciences Inc. funding round, December 2020: $80.02m
Sagimet Biosciences Inc. , February 2021
$80m
Sagimet Biosciences Inc. Series E round, August 2019
$25m
Sagimet Biosciences Inc. funding round, December 2020
$80.02m
Industries
Sagimet Biosciences Inc. is active in the following industries:
- Enzyme kinetics
- Drug metabolism
- Chemistry
- Pharmacokinetics
- Biotechnology
- Engineering
- Biomedical engineering